Back to companies

Vaxcell-Bio Therapeutics

323990KRKRX

박셀바이오

Revenue
₩1.9bn
FY2024
Operating income
-₩15.0bn
FY2024
Employees
—
Founded
—

Source: Korea Financial Supervisory Service DART (Open DART API)